SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001571049-15-003953
Filing Date
2015-05-11
Accepted
2015-05-11 16:50:04
Documents
4
Period of Report
2015-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K t1501117_8k.htm 8-K 21471
2 EXHIBIT 99.1 t1501117_ex99-1.htm EX-99.1 266423
3 EXHIBIT 99.2 t1501117_ex99-2.htm EX-99.2 7522
4 GRAPHIC logo.jpg GRAPHIC 15999
  Complete submission text file 0001571049-15-003953.txt   319103
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

IRS No.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36410 | Film No.: 15851462
SIC: 2834 Pharmaceutical Preparations